(Q43115874)

14 November 2017

title

Prospective association of dopamine-related polymorphisms with smoking cessation in general care (English)

1 reference

14 November 2017

0 references

6

1 reference

14 November 2017

2

Dorothee Twardella

0 references

author name string

Lutz P Breitling

1

1 reference

14 November 2017

Dorothee Twardella

2

1 reference

14 November 2017

Michael M Hoffmann

3

1 reference

14 November 2017

Stephanie H Witt

4

1 reference

14 November 2017

Jens Treutlein

5

1 reference

14 November 2017

publication date

1 April 2010

1 reference

14 November 2017

1 reference

14 November 2017

volume

11

1 reference

14 November 2017

issue

4

1 reference

14 November 2017

page(s)

527-536

1 reference

Treating tobacco dependence: state of the science and new directions

14 November 2017

cites work

1 reference

The genetic determinants of smoking

21 January 2018

1 reference

Identifying susceptibility loci for nicotine dependence: 2008 update based on recent genome-wide linkage analyses

21 January 2018

1 reference

Overview of the pharmacogenomics of cigarette smoking

21 January 2018

1 reference

Pharmacogenetics and nicotine addiction treatment

21 January 2018

1 reference

Genetics and smoking cessation improving outcomes in smokers at risk

21 January 2018

1 reference

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch

21 January 2018

1 reference

Effects of practitioner education, practitioner payment and reimbursement of patients' drug costs on smoking cessation in primary care: a cluster randomised trial

21 January 2018

1 reference

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change

21 January 2018

1 reference

Biochemical verification of tobacco use and cessation

21 January 2018

1 reference

The need for dissemination of evidence-based results from research on nicotine and tobacco

21 January 2018

1 reference

Multiple comparisons and related issues in the interpretation of epidemiologic data

21 January 2018

1 reference

The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood

21 January 2018

1 reference

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial

21 January 2018

1 reference

Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR.

21 January 2018

1 reference

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial

21 January 2018

1 reference

Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation

21 January 2018

1 reference

Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study

21 January 2018

1 reference

Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications

21 January 2018

1 reference

The genetic basis for smoking behavior: a systematic review and meta-analysis

21 January 2018

1 reference

Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample.

21 January 2018

1 reference

Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1.

21 January 2018

1 reference

Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations.

21 January 2018

1 reference

Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?

21 January 2018

1 reference

The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study

21 January 2018

1 reference

Molecular heterosis: a review

21 January 2018

1 reference

Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density

21 January 2018

1 reference

Gender-specific molecular heterosis and association studies: dopamine D2 receptor gene and smoking.

21 January 2018

1 reference

Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia

21 January 2018

1 reference

Assortative mating for cigarette smoking and for alcohol consumption in female Australian twins and their spouses.

21 January 2018

1 reference

Genetic research on nicotine dependence will facilitate public health

21 January 2018

1 reference

Will nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases?

21 January 2018

1 reference

Lack of training as a central barrier to the promotion of smoking cessation: a survey among general practitioners in Germany

21 January 2018

1 reference

Hardy–Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations and power

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.10.1

1 reference

14 November 2017

1 reference